Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Bone Marrow Stem Cells Infusion Through Hepatic Artery in Open Abdominal Portal Hypertension Surgery for the Treatment of Liver Cirrhosis: a Prospective, Non-randomized, Controlled Study

NCT01560845 is registered in ClinicalTrials.gov with Wenzhou Medical University as lead sponsor.

NCT NCT01560845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01560845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Bone Marrow Stem Cells Infusion Through Hepatic Artery in Open Abdominal Portal Hypertension Surgery for the Treatment of Liver Cirrhosis: a Prospective, Non-randomized, Controlled Study
Lead sponsor
Wenzhou Medical University
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 30, 2010
Completion date
June 30, 2014
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic decompensation, liver cirrhosis, portal hypertension, surgery